Skip to main content

Postoperative Surveillance of Main Duct IPMN

  • Chapter
  • First Online:
Intraductal Papillary Mucinous Neoplasm of the Pancreas
  • 902 Accesses

Abstract

Surveillance schedule after resection of main duct IPMNs (MD-IPMNs) is determined based on pathological grade and surgical margin status. Prognosis after resection of invasive IPMNs is better than that of conventional pancreatic ductal adenocarcinomas (PDACs) in the matched status of T1 or N0, or the subtype of colloid carcinoma, while it is not different from that of PDACs in the other conditions (T2 to T4, N1, or other subtypes of carcinoma). Thus, the patients with invasive MD-IPMNs should be basically surveyed according to the protocol of the PDACs. In noninvasive IPMNs (low- to intermediate-grade dysplasia), if there is no residual lesion in the remnant pancreas with negative surgical margin, then the patients might be surveyed at 2 and 5 years after operation to check the development of new lesions in the remnant pancreas. In the patients having positive surgical margin of low- to intermediate-grade dysplasia, the surveillance of twice a year using physical examination and magnetic resonance imaging (MRI) might be suitable, although there has been no evidence regarding the effect of this protocol. On the other hand, it remains unclear whether this surveillance protocol of twice a year would be also applied to the patients after resection for noninvasive carcinoma (high-grade dysplasia). If there are some clinical signs to suspect the progression of the diseases in such patients, then surveillance with shorter interval is recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500–7.

    Article  PubMed  Google Scholar 

  • Couvelard A, Sauvanet A, Kainmanesh R, et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable. Ann Surg. 2005;242:774–80.

    Article  PubMed  Google Scholar 

  • Furukawa T, Hatori T, Fujita I, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:509–16.

    Article  PubMed  Google Scholar 

  • Hwang DW, Jang JY, Lee SE, et al. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution. Langenbecks Arch Surg. 2012;397:93–102.

    Article  PubMed  Google Scholar 

  • Inagaki M, Maguchi M, Kino S, et al. Mucin-producing tumors of the pancreas: clinicopathological features, surgical treatment, and outcome. J Hepatobiliary Pancreat Surg. 1999;6:281–5.

    Article  PubMed  CAS  Google Scholar 

  • Kikuyama M, Itoi T, Ota Y, et al. Therapeutic endoscopy for stenotic pancreatodigestive tract anastomosis after pancreatoduodenectomy. Gastrointest Endosc. 2012;73:376–82.

    Article  Google Scholar 

  • Matthaei H, Norris AL, Tsiatis AC, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255:326–33.

    Article  PubMed  Google Scholar 

  • Mino-Kenudson M, Fernández-del Castillo C, Baba Y, et al. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut. 2011;60:1712–20.

    Article  PubMed  Google Scholar 

  • Nagai K, Doi R, Kida A, et al. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg. 2008;32:271–8.

    Article  PubMed  Google Scholar 

  • NCCN clinical practice guidelines in oncology (NCCN Guidelines â„¢). Pancreatic adenocarcinoma. Version I 2012. 2012. http://www.nccn.org.

  • Ohtsuka T, Kono H, Tanabe R, et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas: special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg. 2012;204:44–8.

    Article  PubMed  Google Scholar 

  • Okada K, Imaizumi T, Hirabayashi K, et al. The distance of the tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it. J Hepatobiliary Pancreat Sci. 2010;17:516–22.

    Article  PubMed  Google Scholar 

  • Partelli S, Fernández-del Castillo C, Bassi C, et al. Invasive intraductal papillary mucinous carcinomas of the pancreas. Predictors of survival and the role of lymph node ratio. Ann Surg. 2010;251:477–82.

    Article  PubMed  Google Scholar 

  • Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010;251:470–6.

    Article  PubMed  Google Scholar 

  • Reid-Lombardo KM, Mathis KL, Wood CM, et al. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasm of the pancreas. Implication for management. Ann Surg. 2010;251:64–9.

    Article  PubMed  Google Scholar 

  • Sadakari Y, Ohuchida K, Nakata K, et al. Invasive carcinoma derived from non-intestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from intestinal type. Surgery. 2010;147:812–7.

    Article  PubMed  Google Scholar 

  • Salvia R, Fernández-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas. Clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678–87.

    Article  PubMed  Google Scholar 

  • Serikawa M, Sasaki T, Fujimoto Y, et al. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol. 2006;40:856–62.

    Article  PubMed  Google Scholar 

  • Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas. An updated experience. Ann Surg. 2004;239:788–99.

    Article  PubMed  Google Scholar 

  • Sugiyama M, Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 1999;94:470–3.

    Article  PubMed  CAS  Google Scholar 

  • Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–97.

    Article  PubMed  Google Scholar 

  • Wada K, Kozarek RA, Traverso LW. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2005;189:632–7.

    Article  PubMed  Google Scholar 

  • White R, D’Angelica M, Katabi N, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007;204:987–95.

    Article  PubMed  Google Scholar 

  • Yopp AC, Katabi N, Janakos M, et al. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas. A match control study with conventional pancreatic ductal adenocarcinoma. Ann Surg. 2011;253:968–74.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takao Ohtsuka .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

Ohtsuka, T., Tanaka, M. (2014). Postoperative Surveillance of Main Duct IPMN. In: Tanaka, M. (eds) Intraductal Papillary Mucinous Neoplasm of the Pancreas. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54472-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54472-2_15

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54471-5

  • Online ISBN: 978-4-431-54472-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics